Royal Bank of Canada
KLDO

Royal Bank of Canada’s Kaleido Biosciences, Inc. Common Stock KLDO Stock Holding History

Royal Bank of Canada’s Portfolio KLDO Stock Details KLDO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-1,366
Closed -$2K – 8212
2022
Q1 		$2K Sell
1,366
-3,960
-74% -$7.07K ﹤0.01% 7549
2021
Q4 		$12K Buy
5,326
+2,028
+61% +$8.26K ﹤0.01% 7017
2021
Q3 		$18K Buy
3,298
+1,196
+57% +$7.42K ﹤0.01% 6761
2021
Q2 		$15K Buy
2,102
+71
+3% +$503 ﹤0.01% 6726
2021
Q1 		$17K Buy
2,031
+863
+74% +$9.4K ﹤0.01% 6548
2020
Q4 		$10K Buy
1,168
+568
+95% +$4.66K ﹤0.01% 6401
2020
Q3 		$7K Buy
600
+573
+2,122% +$3.97K ﹤0.01% 6068
2020
Q2 		$0 Sell
27
-8
-23% -$54 ﹤0.01% 7068
2020
Q1 		$0 Sell
35
-563
-94% -$3.67K ﹤0.01% 7193
2019
Q4 		$3K Buy
598
+497
+492% +$3.16K ﹤0.01% 6517
2019
Q3 		$1K Buy
101
+1
+1% +$9 ﹤0.01% 6581
2019
Q2 		$1K Buy
+100
New +$1.46K ﹤0.01% 6776

Other funds holding KLDO

AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Royal Bank of Canada's KLDO Position: Q2 2022 in Review

Royal Bank of Canada sold out of Kaleido Biosciences, Inc. Common Stock (KLDO) in Q2 2022, closing a stake of 1,366 shares — an estimated $2K sold.

Royal Bank of Canada first reported a position in KLDO in Q2 2019 and held it in 12 quarters. The position peaked at $18K in Q3 2021. 3 funds tracked by Wall St. Rank hold KLDO as of Q2 2022.

  • Royal Bank of Canada reported no remaining Kaleido Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Royal Bank of Canada sold 1,366 Kaleido Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $2K.
  • Royal Bank of Canada first reported a position in Kaleido Biosciences, Inc. Common Stock in Q2 2019 and held it in 12 quarters.
  • Royal Bank of Canada's Kaleido Biosciences, Inc. Common Stock position peaked at $18K in Q3 2021.
  • 3 funds tracked by Wall St. Rank held Kaleido Biosciences, Inc. Common Stock as of Q2 2022.

Based on Royal Bank of Canada's 13F filing for Q2 2022, filed 15 Aug 2022.